treprostinil diethanolamine
TDE-PH-123
Phase 1 small_molecule completed
Quick answer
treprostinil diethanolamine for Pulmonary Arterial Hypertension is a Phase 1 program (small_molecule) at United Therapeutics Europe Ltd with 2 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- Pulmonary Arterial Hypertension
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed